Patients' attitudes towards and experiences of generic drug substitution in Norway

Pharmacy World and Science

Volumn 28, Issue 5, 2006, Pages 284-289

  Kjoenniksen, Inge ^a   Lindbaek, Morten ^b   Granas, Anne Gerd ^a  

^a Institute for Pharmacy Practice Research   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Community pharmacy; Generic substitution; Norway; Patient experience

Indexed keywords

GENERIC DRUG;

ADULT; AGE; AGED; ARTICLE; DRUG CLASSIFICATION; DRUG INFORMATION; DRUG SUBSTITUTION; ECONOMIC ASPECT; EXPERIENCE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PATIENT ATTITUDE; PATIENT SATISFACTION; PHYSICIAN; POLYPHARMACY; POSTAL MAIL; PRESCRIPTION; QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PATIENTS;

EID: 33845331688     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9043-5     Document Type: Article

References (18)

1. Aarseth HP. Why generic substitution? (In Norwegian). Tidskr Nor Laegefor 2001;121(28):3339.
2. Husom N. Generic substitution - not at any price (In Norwegian). Tidskr Nor Laegefor 2004;124(16):2165.
3. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther 2003;25(11):2875-90.
4. Tilyard MW, Dovey SM, Rosenstreich D. General practitioners' views on generic medication and substitution. N Z Med J 1990;103(893):318-20.
5. Colaizzi JL, Lowenthal DT. Critical therapeutic categories: a contraindication to generic substitution? Clin Ther 1986;8(4):370-9.
6. Reiffel JA. Issues in the use of generic antiarrhythmic drugs. Curr Opin Cardiol 2001;16(1):23-29.
7. Welty TE, Pickering PR, Hale BC, Arazi R. Loss of seizure control associated with generic substitution of carbamazepine. Ann Pharmacother 1992;26(6):775-7.
8. Williamson IJ, Reid A, Monie RD, Fennerty AG, Rimmer EM. Generic inhaled salbutamol versus branded salbutamol. A randomised double-blind study. Postgrad Med J 1997;73(857):156-8.
9. Murphy JE. Generic substitution and optimal patient care. Arch Intern Med 1999;159(5):429-33.
10. Banahan BF, III, Kolassa EM. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med 1997;157(18):2080-88.
11. Nordling S, Lindberg G, Sandberg S, Anell A, Melander A, Rydberg T. Hur gikk det med försöket med generisk substitusjon i Skåne? En rapport från IHE, NEPI og Apoteken i Skåne. (In Swedish) 2000. Kristianstad, Apotekarsocieteten. ISBN 91-8627-489-9.
12. Madsen S, Huse J, Roksvaag PO. [Pharmacy customers' attitude to generics] In Norwegian. Tidsskr Nor Laegeforen 2003;123(6):792-3.
13. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc 2000;40(3):378-83.
14. Mott DA, Cline RR. Exploring generic drug use behaviour: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002;40(8):662-74.
15. Suh DC. Trends of generic substitution in community pharmacies. Pharm World Sci 1999; 21(6):260-5.
16. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med 2005;142(11):891-7.
17. Lund-Jacobsen B. [Generic substitution - patients' incentives are too low]. Ugeskr Laeger 1992;154(46):3215-6.
18. Andersson K, Sonesson C, Petzold M, Carlsten A, Lonnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf 2005;14(5):341-8.